D. Hammond

发表

Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas.

H. Sather, R. Seeger, G. Brodeur, 1985, The New England journal of medicine.

Evaluation of a new concentrate for the treatment of factor IX deficiency.

D. Hammond, H. Ekert, E. Shanbrom, 1969, The New England journal of medicine.

5-(3,3-Dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388) in the treatment of solid tumors in children.

D. Hammond, J. Finklestein, V. Albo, 1975, Cancer chemotherapy reports.

PARANEOPLASTIC ERYTHROCYTOSIS AND ECTOPIC ERYTHROPOIETINS *

D. Hammond, S. Winnick, Sheldon Winnick, 1974, Annals of the New York Academy of Sciences.

Opportunities for cancer prevention and early detection among children

D. Hammond, 1988, Cancer.

Septicemia and meningitis in children splenectomized for hodgkin's disease.

D. Hammond, R. Baehner, R. Chilcote, 1976, The New England journal of medicine.

Treatment of Neuroblastoma Patients with Antiganglioside GD2 Antibody plus Interleukin‐2 Induces Antibody‐Dependent Cellular Cytotoxicity Against Neuroblastoma Detected In Vitro

R. Seeger, R. Reisfeld, T. Chew, 1994, Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy.

L-Asparaginase, vincristine, and prednisone for induction of first remission in acute lymphocytic leukemia.

D. Hammond, J. Weiner, J. Ortega, 1977, Cancer research.

Comparison of stage IV and IV-S neuroblastoma in the first year of life.

H. Sather, D. Hammond, J. Grosfeld, 1985, Medical and pediatric oncology.

Results in children with local and regional neuroblastoma managed with and without vincristine, cyclophosphamide, and imidazolecarboxamide: A report from the Children's Cancer Study Group

H. Sather, S. McCreadie, D. Hammond, 1984, American journal of clinical oncology.

Phase II study of cis-dichlorodiammineplatinum(II) in childhood osteosarcoma: Children's Cancer Study Group Report.

P. Gaynon, D. Hammond, W. Krivit, 1979, Cancer treatment reports.

Improved remission induction rate with D-ZAPO but unimproved remission duration with addition of immunotherapy to chemotherapy in previously untreated children with ANLL.

I. Bernstein, H. Sather, S. McCreadie, 1979, Medical and pediatric oncology.

A new therapy schedule for pediatric non-Hodgkin lymphoma toxicity with preliminary results.

J. Anderson, S. Siegel, D. Hammond, 1980, Medical and pediatric oncology.

The role of surgery in abdominal non-Hodgkin's lymphoma: experience from the Childrens Cancer Study Group.

C. Stolar, M. LaQuaglia, S. Siegel, 1992, Journal of pediatric surgery.

BCG in the treatment of acute lymphocytic leukemia.

N. Breslow, R. Heyn, D. Hammond, 1975, Blood.

Characteristics of children with acute nonlymphocytic leukemia in long-term continuous remission: a report for Childrens Cancer Study Group.

H. Sather, D. Hammond, R. Baehner, 1981, Medical and pediatric oncology.

BCG in the treatment of acute lymphocytic leukemia

N. Breslow, D. Hammond, J. Weiner, 1975 .

Multiagent chemotherapy for children with metastatic neuroblastoma: a report from Childrens Cancer Study Group.

I. Bernstein, H. Sather, A. Evans, 1979, Medical and pediatric oncology.

Serum CD25 Levels During Interleukin‐2 Therapy: Dose Dependence and Correlations with Clinical Toxicity and Lymphocyte Surface sCD25 Expression

R. Bechhofer, D. Hammond, S. Voss, 1992, Journal of immunotherapy : official journal of the Society for Biological Therapy.

RESPONSE TO PNEUMOCOCCAL POLYSACCHARIDE VACCINE IN PATIENTS WITH UNTREATED HODGKIN'S DISEASE Children's Cancer Study Group Report

G. Higgins, A. Ammann, J. Addiego, 1980, The Lancet.

Analysis of prognostic factors in acute lymphoblastic leukemia.

A. Bleyer, H. Sather, J. Lukens, 1986, Medical and pediatric oncology.

Induction of remission in acute leukemia with prednisone and intravenous methotrexate.

D. Hammond, N. Shore, G. Gilchrist, 1968, The Journal of pediatrics.

TRIAL OF HYDROXYUREA (NSC-32065) IN CANCER IN CHILDREN.

D. Hammond, J. Hartmann, N. Shore, 1964, Cancer chemotherapy reports.

PRODUCTION, UTILIZATION AND EXCRETION OF ERYTHROPOIETIN: I. CHRONIC ANEMIAS. II. APLASTIC CRISIS. III. ERYTHROPOIETIC EFFECTS OF NORMAL PLASMA *

D. Hammond, N. Shore, N. Movassaghi, 1968, Annals of the New York Academy of Sciences.

Phase II trial of a complex polyriboinosinic-polyribocytidylic acid with poly-L-lysine and carboxymethyl cellulose in the treatment of children with acute leukemia and neuroblastoma: a report from the Children's Cancer Study Group.

A. Levine, B. Lampkin, D. Hammond, 1985, Cancer research.

Phase II trial of poly(I,C)-LC, an interferon inducer, in the treatment of children with acute leukemia and neuroblastoma: a report from the Children's Cancer Study Group.

A. Levine, B. Lampkin, D. Hammond, 1985, Journal of biological response modifiers.

Contrasting benefits of two maintenance programs following identical induction in children with acute nonlymphocytic leukemia: a report from the Childrens Cancer Study Group.

I. Bernstein, H. Sather, S. McCreadie, 1984, Cancer treatment reports.

The hemolytic uremic syndrome. Renal cortical thrombotic microangiopathy.

D. Hammond, E. Lieberman, 1970, Archives of internal medicine.

Effective dose of L-asparaginase for induction of remission in previously treated children with acute lymphocytic leukemia: a report from Childrens Cancer Study Group.

H. Sather, D. Hammond, J. Weiner, 1979, Cancer research.

Pediatric phase I trial and pharmacokinetic study of topotecan administered as a 24-hour continuous infusion.

F. Balis, G. Reaman, J. Reid, 1993, Cancer research.

Hemostasis in cyanotic congenital heart disease.

D. Hammond, H. Ekert, R. Stanton, 1970, The Journal of pediatrics.

Hemophilia A in a phenotypically normal female with XX-XO mosaicism.

D. Hammond, J. Melnyk, G. Gilchrist, 1965, The New England journal of medicine.

Definition of Cooley's Trait or Thalassemia Minor: Classical, Clinical and Routine Laboratory Hematology *

D. Hammond, P. Sturgeon, A. Caviles, 1964, Annals of the New York Academy of Sciences.

The Third Intergroup Rhabdomyosarcoma Study.

E. Gehan, S. Donaldson, R. Heyn, 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The intergroup rhabdomyosarcoma study‐II

E. Gehan, S. Donaldson, M. Beltangady, 1993, Cancer.

Additive therapy in the maintenance of remission in acute lymphoblastic leukemia of childhood: The effect of the initial leukocyte count

Denis R. Miller, D. Hammond, M. Karon, 1974, Cancer.

Treatment of Pneumocystis carinii Pneumonitis: A Comparative Trial of Sulfamethoxazole-Trimethoprim v Pentamidine in Pediatric Patients With Cancer: Report From the Childrens Cancer Study Group

S. Siegel, D. Hammond, R. Baehner, 1984 .

The intergroup rhabdomyosarcoma study‐I. A final report

E. Gehan, M. Beltangady, R. Heyn, 1988, Cancer.

Immunologic evaluation in the prognosis of acute lymphoblastic leukemia. A report from Childrens Cancer Study Group.

H. Sather, D. Hammond, S. Leikin, 1981, Blood.

PREDNISONE IN CHILDHOOD LEUKEMIA

D. Hammond, P. Sturgeon, C. Hyman, 1959, Pediatrics.

RAISED NEURON-SPECIFIC ENOLASE IN SERUM OF CHILDREN WITH METASTATIC NEUROBLASTOMA A Report from the Children's Cancer Study Group

H. Sather, R. Seeger, A. Dalton, 1983, The Lancet.

Enhancement of erythropoiesis by prostaglandins.

D. Hammond, N. Shore, P. P. Dukes, 1973, The Journal of laboratory and clinical medicine.

Disappearance of the predictive value of prognostic variables in childhood acute lymphoblastic leukemia: A report from childrens cancer study group

H. Sather, D. Hammond, P. Coccia, 1981, Cancer.

DIFFERENCES IN PROGNOSIS FOR BOYS AND GIRLS WITH ACUTE LYMPHOBLASTIC LEUKAEMIA

Denis R. Miller, H. Sather, R. Heyn, 1981, The Lancet.

Tumors of the pineal and suprasellar region: Childrens cancer study group treatment results 1960–1975. A report from childrens cancer study group

Charles B. Wilson, W. Wara, A. Evans, 1979, Cancer.

The intergroup rhabdomyosarcoma study. A preliminary report

E. Gehan, D. Hammond, T. Moon, 1977, Cancer.

Clinical implications of oncogene activation in human neuroblastomas

H. Sather, R. Seeger, G. Brodeur, 1986, Cancer.

Central nervous system (CNS) prophylaxis in children with low risk acute lymphoblastic leukemia (ALL).

A. Bleyer, H. Sather, J. Lukens, 1984, International journal of radiation oncology, biology, physics.

Evaluation of radiation therapy factors in prophylactic central nervous system irradiation for childhood leukemia: a report from the Children's Cancer Study Group.

H. Sather, D. Hammond, J. Ortega, 1981, International journal of radiation oncology, biology, physics.

COMPARISON OF THREE METHODS OF CENTRAL-NERVOUS-SYSTEM PROPHYLAXIS IN CHILDHOOD ACUTE LYMPHOBLASTIC LEUKÆMIA

D. Green, H. Sather, J. Cassady, 1980, The Lancet.

The Role of Erythropoietin in the Regulation of Red Cell Production*

D. Hammond, P. P. Dukes, 1971, Advances in Pediatrics.

Evaluation of cyclocytidine in reinduction and maintenance therapy of children with acute nonlymphocytic leukemia previously treated with cytosine arabinoside: a report from Children's Cancer Study Group.

H. Sather, D. Hammond, R. Baehner, 1984, Medical and pediatric oncology.

Usefulness of cytosine arabinoside (NSC-63878) and prednisone (NSC-10023) in refractory childhood lymphoblastic leukemia.

D. Hammond, M. Nesbit, M. Sonley, 1976, Medical and pediatric oncology.

Current status of the biology and treatment of acute non-lymphocytic leukemia in children (report from the ANLL strategy group of the Children's Cancer Study Group.

I. Bernstein, S. Feig, A. Bleyer, 1983, Blood.

Comparison of the therapeutic response of patients with childhood acute lymphoblastic leukemia in relapse to vindesine versus vincristine in combination with prednisone and L-asparaginase: a phase III trial.

J. Anderson, D. Hammond, W. Krivit, 1981, Cancer treatment reports.

Human leukocyte interferon for the treatment of varicella in children with cancer.

T. Merigan, D. Hammond, A. Arvin, 1982, The New England journal of medicine.

Biochemical pharmacology of 3-deazaguanine (3-dg). Abstr.

D. Hammond, P. Schwartz, T. A. Khwaga, 1977 .

The effect of methotrexate on the bioavailability of oral 6‐mercaptopurine

R. Murphy, F. Balis, D. Hammond, 1987, Clinical pharmacology and therapeutics.

Evaluation of cyclocytidine in children with advanced acute leukemia and solid tumors.

D. Hammond, W. Krivit, J. Finklestein, 1979, Cancer treatment reports.

Incomplete Erythropoietin Activity in Normal Plasma Components 1

D. Hammond, P. P. Dukes, Peter P. Dukes, 1971, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

Erythropoietin: a complex with different in vivo and in vitro activities.

D. Hammond, N. Shore, P. P. Dukes, 1970, The Journal of laboratory and clinical medicine.

Comparison of erythropoietin preparations yielding different dose-response slopes in the exhypoxic polycythemic mouse assay.

D. Hammond, N. Shore, P. P. Dukes, 1969, The Journal of laboratory and clinical medicine.

Serum and Urinary Levels of Erythropoietin in Iron Deficiency Anemia.∗

D. Hammond, N. Shore, N. Movassaghi, 1967 .

A study of the cross-resistance of vincristine and vindesine in reinduction therapy for acute lymphocytic leukemia in relapse. A report for Children's Cancer Study Group.

J. Anderson, D. Hammond, W. Krivit, 1980, The American journal of pediatric hematology/oncology.

The effectiveness of chemotherapy for treatment of high grade astrocytoma in children: Results of a randomized trial

Audrey E. Evans, A. Evans, D. Hammond, 1989, Journal of Neuro-Oncology.

Prognostic factors and therapy in acute lymphoblastic leukemia of childhood: CCG‐141: A report from childrens cancer study group

Denis R. Miller, H. Sather, D. Hammond, 1983, Cancer.

Cytogenetic features of infants less than 12 months of age at diagnosis of acute lymphoblastic leukemia: impact of the 11q23 breakpoint on outcome: a report of the Childrens Cancer Group.

N. Heerema, H. Sather, B. Lange, 1994, Blood.

Cytoreduction and prognosis in acute lymphoblastic leukemia--the importance of early marrow response: report from the Childrens Cancer Group.

H. Sather, P. Steinherz, M. Trigg, 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Potential long-term toxic effects in children treated for acute lymphoblastic leukemia.

L. Robison, J. Neglia, H. Sather, 1989, The New England journal of medicine.

Childhood non-Hodgkin's lymphoma. The results of a randomized therapeutic trial comparing a 4-drug regimen (COMP) with a 10-drug regimen (LSA2-L2).

James R. Anderson, J. Kersey, S. Siegel, 1983, The New England journal of medicine.

Prognostic importance of serum ferritin in patients with Stages III and IV neuroblastoma: the Childrens Cancer Study Group experience.

H. Sather, R. Seeger, A. Evans, 1985, Cancer research.

TRANSIENT CONGENITAL LEUKEMIA IN 7 INFANTS WITH MONGOLISM.

R. Engel, D. Hammond, W. Krivit, 1964, The Journal of pediatrics.

Vincristine in the treatment of acute leukemia in children.

R. Heyn, D. Hammond, M. Murphy, 1966, Pediatrics.

Leukemia in Children

D. Hammond, G. Gilchrist, M. Karon, 2006 .

Lymphomatous presentation of childhood acute lymphoblastic leukemia. A subgroup at high risk of early treatment failure

Denis R. Miller, H. Sather, G. Reaman, 1991, Cancer.

Use of prognostic factors in improving the design and efficiency of clinical trials in childhood leukemia: Children's Cancer Study Group Report.

H. Sather, D. Hammond, S. Leikin, 1980, Cancer treatment reports.

Mediastinal mass in acute lymphoblastic leukemia.

L. Robison, H. Sather, D. Hammond, 1984, Medical and pediatric oncology.

Acute lymphoblastic leukemia in infants less than one year of age: a cumulative experience of the Children's Cancer Study Group.

H. Sather, B. Amendola, G. Reaman, 1985, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Congenital hypoplastic anemia inhibition of erythropoiesis by sera from patients with congenital hypoplastic anemia.

D. Hammond, J. Ortega, N. Shore, 1975, Blood.

Down syndrome and acute leukemia in children: a 10-year retrospective survey from Childrens Cancer Study Group.

L. Robison, H. Sather, D. Hammond, 1984, The Journal of pediatrics.

Hypergammaglobulinemia in histiocytosis X.

W. Wara, R. Heyn, D. Hammond, 1985, The Journal of pediatrics.

Phase II trail cisplatin in refractory childhood cancer: Children's Cancer Study Group Report.

P. Gaynon, D. Hammond, W. Krivit, 1981, Cancer treatment reports.

An evaluation of the role of surgery in disseminated neuroblastoma: a report from the Children's Cancer Study Group.

I. Bernstein, H. Sather, D. Hammond, 1983, Journal of pediatric surgery.

Studies on the pathology of non‐Hodgkin's lymphoma of childhood: I. The role of routine histopathology as a prognostic factor a report from the childrens cancer study group

R. Sposto, J. Kersey, S. Siegel, 1984, Cancer.

Paediatric Non-Hodgkin’s Lymphomas: The Childrens’ Cancer Study Group Experience

James R. Anderson, J. Kersey, S. Siegel, 1982 .

Paediatric non-Hodgkin's lymphomas: The Children's Cancer Study Group experience. An interim report.

J. Kersey, S. Siegel, D. Hammond, 1981, Frontiers of radiation therapy and oncology.

Histiocytosis X: clinical trial of chlorambucil: a report from Childrens Cancer Study Group.

R. Heyn, D. Hammond, S. Leikin, 1979, Medical and pediatric oncology.

The influence of exogenous iron on formation of hemoglobin in the premature infant.

D. Hammond, A. Murphy, 1960, Pediatrics.

Testicular relapse in childhood acute lymphoblastic leukemia: Association with pretreatment patient characteristics and treatment. A report for childrens cancer study group

L. Robison, H. Sather, D. Hammond, 1980, Cancer.

Relapse rates following cessation of chemotherapy during complete remission of acute lymphocytic leukemia.

H. Sather, D. Hammond, W. Krivit, 1979, Medical and pediatric oncology.

Intensive therapy and prognostic factors in acute lymphoblastic leukemia of childhood:CCG 141. A report from Childrens Cancer Study Group.

H. Sather, D. Hammond, S. Leikin, 1981, Haematology and blood transfusion.

THE SUSTAINED ACTION OF ERYTHROPOIETIN INJECTED REPEATEDLY INTO RATS AND MICE.

D. Hammond, P. Lowy, G. Keighley, 1964, Blood.

Brain tumors in children: current cooperative and institutional chemotherapy trials in newly diagnosed and recurrent disease.

W. Wara, R. Sposto, A. Evans, 1986, Seminars in oncology.

Absence of neurotoxicity following massive intrathecal administration of methotrexate. Case report

B. Lampkin, D. Hammond, G. Higgins, 1967, Cancer.

Acute nonlymphocytic leukemias of childhood. Inter‐observer variability and problems in the use of the fab classification

D. Hammond, B. Lampkin, J. C. Argyle, 1989, Cancer.

Effective combination treatment of advanced acute lymphocytic leukemia with cytosine arabinoside (NSC-63878) and L-asparaginase (NSC-109229).

D. Hammond, J. Finklestein, J. Ortega, 1972, Cancer chemotherapy reports.

Nasopharyngeal carcinoma—a retrospective review of patients less than thirty years of age: A report from childrens cancer study group

James R. Anderson, W. Wara, D. Hammond, 1981, Cancer.

YIELD OF UNPREDICTED BONE-MARROW RELAPSE DIAGNOSED BY ROUTINE MARROW ASPIRATION IN CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKAEMIA A Report from the Children's Cancer Study Group

H. Sather, D. Hammond, P. Coccia, 1984, The Lancet.

Phase II study of VP-16-213 in childhood malignant disease: a Children's Cancer Study Group Report.

D. Hammond, W. Krivit, W. Bleyer, 1979, Cancer treatment reports.

Treatment of rhabdomyosarcoma in children with surgery, radiotherapy and chemotherapy.

N. Breslow, R. Holland, R. Heyn, 1977, Medical and pediatric oncology.

Pediatrie Phase I Trial and Pharmacokinetic Study of Topotecan Administered as a 24-Hour Continuous Infusion 1

F. Balis, G. Reaman, J. Reid, 2006 .

Current Neurosurgical Treatment of Medulloblastomas in Children

J. Wisoff, M. Deutsch, J. Finlay, 1989 .

Current neurosurgical treatment of medulloblastomas in children. A report from the Children's Cancer Study Group.

J. Wisoff, M. Deutsch, J. Finlay, 1989, Pediatric neuroscience.

Prognostic Importance of Morphology (FAB Classification) in Childhood Acute Lymphoblastic Leukaemia (ALL)

Denis R. Miller, H. Sather, D. Hammond, 1981, British journal of haematology.

Childrens Cancer Group Transplant Trials for Acute Myeloid Leukemia in Children: A Cross-Study Analysis of CCG-251, CCG-213, CCG-2861, and CCG-2891

S. Feig, J. Buckley, W. Woods, 1994 .

Phase II study of VM-26 in acute leukemia, neuroblastoma, and other refractory childhood malignancies: a report from the Children's Cancer Study Group.

D. Hammond, W. Krivit, W. Bleyer, 1979, Cancer treatment reports.

Prognostic implications of blast cell morphology in childhood acute lymphoblastic leukemia: a report from the Childrens Cancer Study Group.

J. Lukens, S. Siegel, D. Hammond, 1985, Cancer treatment reports.

Differences between in vivo and in vitro activities of various erythropoietin preparations.

D. Hammond, N. Shore, P. P. Dukes, 1971, Israel journal of medical sciences.

Humoral hematopoietic factors in the control of erythrocyte production.

D. Hammond, 1962, Pediatric clinics of North America.

Prognostic importance of serum neuron specific enolase in local and widespread neuroblastoma.

H. Sather, R. Seeger, A. Dalton, 1985, Progress in clinical and biological research.

Childhood leukemia-lymphoma. Heterogeneity of phenotypes and prognoses.

R. Hurwitz, T. Lebien, J. Kersey, 1979, American journal of clinical pathology.

Ten-year survival of children with acute lymphoblastic leukemia: A report from the Children's Oncology Group

H. Sather, G. Reaman, F. Uckun, 2008, Leukemia & lymphoma.

Phase II trial of indicine N-oxide in relapsed pediatric solid tumors

D. Hammond, W. Krivit, M. Krailo, 1991, Investigational New Drugs.

Leukemia in children.

D. Hammond, G. Gilchrist, M. Karon, 1971, California medicine.

CENTRAL NERVOUS SYSTEM INVOLVEMENT BY LEUKEMIA IN CHILDREN. I. RELATIONSHIP TO SYSTEMIC LEUKEMIA AND DESCRIPTION OF CLINICAL AND LABORATORY MANIFESTATIONS.

D. Hammond, D. Hammond, C. Hyman, 1965, Blood.

CENTRAL NERVOUS SYSTEM INVOLVEMENT BY LEUKEMIA IN CHILDREN. II. THERAPY WITH INTRATHECAL METHOTREXATE.

D. Hammond, D. Hammond, C. Hyman, 1965, Blood.

NEGATIVE ANTIGLOBULIN TESTS IN HEMOLYTIC DISEASE OF THE NEWBORN.

D. Hammond, A. Caviles, M. Sonley, 1964, Bibliotheca haematologica.

Influence of age, sex, and concurrent intrathecal methotrexate therapy on intellectual function after cranial irradiation during childhood: a report from the Children's Cancer Study Group.

L. Robison, L. Constine, H. Sather, 1990, Pediatric hematology and oncology.

Dibromodulcitol (NSC-104800) compared with cyclophosphamide (NSC-26271) as remission maintenance therapy in previously treated children with acute lymphoblastic leukemia or acute undifferentiated leukemia: possible effectiveness in reducing the incidence of central nervous system leukemia.

D. Hammond, J. Weiner, M. Karon, 1975, Cancer chemotherapy reports.

Cyclophosphamide (NSC-26271) maintenance therapy after a second remission of childhood acute lymphoblastic leukemia: comparative clinical trial (standard dose versus intermittent high dose versus cyclophosphamide plus cytosine arabinoside (NSC-63878)).

D. Hammond, J. Weiner, Sitarz Al, 1975, Cancer chemotherapy reports.

The human homologue of rat NG2, a chondroitin sulfate proteoglycan, is not expressed on the cell surface of normal hematopoietic cells but is expressed by acute myeloid leukemia blasts from poor-prognosis patients with abnormalities of chromosome band 11q23.

I. Bernstein, D. Williams, J. Buckley, 1996, Blood.

Unfavorable prognostic significance of hand mirror cells in childhood acute lymphoblastic leukemia. A report from the childrens Cancer Study Group.

H. Sather, P. Steinherz, D. Hammond, 1983, American journal of diseases of children.

The surgical management of children with incompletely resected hepatic cancer is facilitated by intensive chemotherapy.

J. Quinn, K. Newman, J. Feusner, 1991, Journal of pediatric surgery.

Post-induction treatment of childhood acute lymphocytic leukemia.

L. Robison, H. Sather, D. Hammond, 1984, The New England journal of medicine.

Radiation therapy (RT) factors in prophylactic central nervous system (CNS) irradiation for childhood leukemia : A report from Children's Study Group (CCSG)

H. Sather, D. Hammond, J. Ortega, 1979 .

A follow-up report of long-term survivors of childhood acute lymphoblastic or undifferentiated leukemia. A report for Childrens Cancer Study Group.

L. Robison, D. Hammond, W. Krivit, 1979, The Journal of pediatrics.

Central nervous system (CNS) prophylaxis in children with low risk acute lymphoblastic leukemia (ALL).

A. Bleyer, H. Sather, J. Lukens, 1984, International journal of radiation oncology, biology, physics.

I. Bernstein, J. Buckley, C. March, 1996, Blood.